POTASSIUM PHOSPHATES
These highlights do not include all the information needed to use POTASSIUM PHOSPHATES INJECTION safely and effectively. See full prescribing information for POTASSIUM PHOSPHATES INJECTION. POTASSIUM PHOSPHATES injection, for intravenous useInitial U.S. Approval: 1983
Approved
Approval ID
2c2078d1-9edc-4d0c-a72a-5491c28a5aac
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 27, 2019
Manufacturers
FDA
CMP PHARMA, INC.
DUNS: 005224175
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
monobasic potassium phosphate and dibasic potassium phosphate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code46287-024
Application NumberNDA212121
Product Classification
M
Marketing Category
C73594
G
Generic Name
monobasic potassium phosphate and dibasic potassium phosphate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 27, 2019
FDA Product Classification
INGREDIENTS (3)
POTASSIUM PHOSPHATE, DIBASICActive
Quantity: 300 mg in 1 mL
Code: CI71S98N1Z
Classification: ACTIB
POTASSIUM PHOSPHATE, MONOBASICActive
Quantity: 175 mg in 1 mL
Code: 4J9FJ0HL51
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT